Cite
HARVARD Citation
De Luca, R. et al. (2018). A novel dual-cytokine–antibody fusion protein for the treatment of CD38-positive malignancies. Protein engineering, design & selection. 31 (5), pp. 173-179. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
De Luca, R. et al. (2018). A novel dual-cytokine–antibody fusion protein for the treatment of CD38-positive malignancies. Protein engineering, design & selection. 31 (5), pp. 173-179. [Online].